These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7989867)

  • 1. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient.
    Lüttmann S; von Eckardstein A; Wei W; Funke H; Köhler E; Mahley RW; Assmann G
    J Lipid Res; 1994 Aug; 35(8):1431-40. PubMed ID: 7989867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin.
    Pullinger CR; Malloy MJ; Shahidi AK; Ghassemzadeh M; Duchateau P; Villagomez J; Allaart J; Kane JP
    J Lipid Res; 1997 Sep; 38(9):1833-40. PubMed ID: 9323592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
    von Eckardstein A; Holz H; Sandkamp M; Weng W; Funke H; Assmann G
    J Clin Invest; 1991 May; 87(5):1724-31. PubMed ID: 2022742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apolipoprotein C-II variant apoC-IILys19-->Thr is not associated with dyslipidemia in an affected kindred.
    Zysow BR; Pullinger CR; Hennessy LK; Farese RV; Ghassemzadeh M; Kane JP
    Clin Genet; 1994 Jun; 45(6):292-7. PubMed ID: 7923858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
    Campos H; Perlov D; Khoo C; Sacks FM
    J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
    J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
    Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL
    J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism.
    Mauger JF; Couture P; Bergeron N; Lamarche B
    J Lipid Res; 2006 Jun; 47(6):1212-8. PubMed ID: 16495512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject.
    Huff MW; Evans AJ; Wolfe BM; Connelly PW; Maguire GF; Strong WL
    J Lipid Res; 1990 Mar; 31(3):385-96. PubMed ID: 2341805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED; Le NA; Li X; Martinson D; Brown WV
    J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation.
    Maeda H; Hashimoto RK; Ogura T; Hiraga S; Uzawa H
    J Lipid Res; 1987 Dec; 28(12):1405-9. PubMed ID: 3123586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Humphries S; Turner PR; Masana L
    J Lipid Res; 1997 Jun; 38(6):1061-9. PubMed ID: 9215535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP; Dory L; Rubinstein D
    J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
    Rozhkova TA; Titov VN; Amelyushkina VA; Kaba SI; Kukhartchuk VV
    Klin Lab Diagn; 2015 Dec; 60(12):4-14. PubMed ID: 27032246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
    Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS
    J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial apolipoprotein A-I and C-III deficiency, variant II.
    Schaefer EJ; Ordovas JM; Law SW; Ghiselli G; Kashyap ML; Srivastava LS; Heaton WH; Albers JJ; Connor WE; Lindgren FT
    J Lipid Res; 1985 Sep; 26(9):1089-101. PubMed ID: 3934306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins.
    Bukberg PR; Le NA; Ginsberg HN; Gibson JC; Rubinstein A; Brown WV
    J Lipid Res; 1985 Sep; 26(9):1047-57. PubMed ID: 4067427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.